By Prakhar Srivastava (Reuters) -Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 ...

The early favorite for the 2025 Heisman Trophy isn’t much of a surprise. Texas QB Arch Manning has opened as the favorite at BetMGM ahead of his first season as the Longhorns’ starter. Manning is +800 ...

"It's great," Manning answered. "I'm so excited about the partnership. Red Bull is a great brand, and when they reached out, it was just like a match made in heaven, and I'm glad ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

In an ongoing effort to combat homelessness and support vulnerable populations, the Board of Supervisors has approved a second amendment to ...

Ten days have elapsed since the 2024 college football season ended. Twenty days have gone by since the Texas Longhorns saw ...

One of the biggest stories of the 2024 college football season had nothing to do with a starting player; well, in a way, it ...

Would Arch Manning or Jeremiah Smith go No. 1? Rob Rang forecasts who every NFL team would target with their 2025 first-round ...

It’s a blue-chip fixture in South African football. The country stands still as Orlando Pirates host Kaizer Chiefs in the iconic Soweto Derby. Orlando Stadium plays host to another battle between ...

It’s never too early to talk about next season so we will. Last season after Ashton Jeanty had an early lead in the opinion ...